Document is current
Any future updates will be listed below
-
Authors
Bermingham, Kate M.
May, Anna
Asnicar, Francesco
Capdevila, Joan
Leeming, Emily R.
Franks, Paul W.
Valdes, Ana M.
Wolf, Jonathan
Hadjigeorgiou, George
Delahanty, Linda M.
Segata, Nicola
Spector, Tim D.
Berry, Sarah E. https://orcid.org/0000-0002-5819-5109
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03479866 at ClinicalTrials.govDocuments that mention this clinical trial
Snack quality and snack timing are associated with cardiometabolic blood markers: the ZOE PREDICT study
https://doi.org/10.1007/s00394-023-03241-6
Blue poo: impact of gut transit time on the gut microbiome using a novel marker
https://doi.org/10.1136/gutjnl-2020-323877
-
Funding
Funding for this research was provided by:
Wellcome Trust
Medical Research Council
Versus Arthritis
European Union Horizon 2020
Chronic Disease Research Foundation
ZOE Ltd
National Institute for Health Research (NIHR) Clinical Research Network (CRN) and Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 27 January 2023
Accepted: 16 August 2023
First Online: 15 September 2023
Declarations
:
: TDS, GH and JW are co-founders of ZOE Ltd. TDS, FA, NS, LMD, PWF, AMV and SEB are consultants to ZOE Ltd. TDS, SEB, JW, GH, LMD, PWF, AMV, JC and AM are in receipt of ZOE options. KMB, AM and JC are employed by ZOE Ltd. Other authors have no conflict of interest to declare.
